Related Articles
miRNA‑542‑3p downregulation promotes trastuzumab resistance in breast cancer cells via AKT activation
Anthocyanins inhibit trastuzumab-resistant breast cancer in vitro and in vivo
Pharmacological blockade of Fatty Acid Synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin™) by transcriptionally inhibiting ‘HER2 super-expression’ occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells
SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab‑resistant ovarian cancer model
Progesterone impairs Herceptin effect on breast cancer cells